Location: Home
  • search
  • go
  • Relate News
  • 12/9/2018Gilead Launches HBV Drug Vemlidy in China
  • 12/7/2018National Centralized Drug Purchase Trial Upsets Pharma Industry with C...
  • 12/7/2018Recent Executive Moves
  • 12/7/2018SAMR Fines Three Violators as It Steps Up Anti-monopoly Crackdown on A...
  • 12/7/2018State Council Approves Patent Amendment Draft and Policies to Boost In...
  • 12/7/2018Brii Bio Announced Partnerships to Jump-start Pipeline with Focus on H...
  • 12/7/2018Oral Insulin Moves Towards Becoming Reality in U.S., China
  • 12/7/2018IFPMA and RDPAC Introduce New Code for Pharmaceutical Marketing Practi...
  • 12/5/2018China Introduces A Range of New Punishments for IP Violations
  • 12/5/2018Changzhou Qianhong Biopharma Expands Facility for Polysaccharides and ...
  • 12/5/2018PAREXEL and Eli Lilly to Develop Chinese Clinical Research Workforce
  • 12/5/2018Wuxi AppTec Says US Hurdles Will Not Dim Acquisition Appetite
  • 12/5/2018BeiGene Mounts Its Assault On The Ibrutinib Hegemony
  • 12/5/2018NMPA Approves Gilead's HIV Combo Drug Descovy
  • 12/5/2018Insurer Manulife-Sinochem Inks Deal with Healthcare Platform 111 Inc.
  • 12/5/2018Innovent Gains US FDA Approval to Initiate Clinical Trials for its Ant...
  • 12/5/2018China Approves New Indication of J&J's Prostate Cancer Drug ZYTIGA
  • 12/4/2018Revance Licenses China Rights of Neuromodulator RT002 to Fosun Pharma
  • 12/4/2018Roche’s Hemlibra (emicizumab) Approved for Import and Marketing in Ch...
  • 12/4/2018SMEI President Predicts Continued Chinese Pharma Growth in 2019
  • 12/4/2018Elpiscience Raises $35 Mln in A+ Round Led by Hillhouse Capital
  • 12/4/2018US Biotech Firms Made China's Gene-Edited Babies Possible
  • 12/4/2018U.S.-China Trade Tensions Threaten Biotech Cash Surge
  • 12/4/2018J&J to Build Blood-Cancer Push With Controversial China Biotech
  • 12/4/2018Sartorius and Immunochina Partner to Advance Immunotherapy Development
  • 12/3/2018AstraZeneca to Promote R&D of Seven New Drugs in China
  • 12/3/2018CASI Pharma Announces Chinese Approval of EVOMELA
  • 12/3/2018Helsinn and Mundipharma China Announce Approval of ALOXI IV by the NMP...
  • 12/3/2018Is Renewed MNC Optimism in China Sustainable amid Intensified Cost Con...
  • 12/3/2018NHC and SMIA Reach Consensus about Use of HTA for BMI Reimbursement Li...
  • Page:301/775 Total number of articles:23235: [First][<<] [299] [300] [301] [302] [303] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group